APhA Annual Meeting & Exposition

In a poster presented at the 2024 American Pharmacists Association Annual Meeting and Exposition, researchers assessed state-level regulations for PBMs.

Researchers presented their findings on hypersensitivity caused by antibiotics as well as the best ways pharmacists can test for it.

In a conversation at this year’s American Pharmacists Association Annual Meeting & Exposition, Sa’ed Al-Olimat outlined the potential of psychedelic therapeutics in treating mental health disorders.

At this year’s American Pharmacists Association Annual Meeting & Exposition, Mark Garofoli urged pharmacists to develop strong documentation practices and go beyond baseline federal regulations to care for patients with red flags.

Pharmacists must uphold their “corresponding responsibility” to address controlled substance concerns among patients while balancing safety and respect, said Mark Garofoli at this year’s American Pharmacists Association Annual Meeting & Exposition.

The average US household spent $645 on OTC products in 2022.

Adults aged 65 years and older are the largest group of consumers of OTC medications.

The first nonprescription, OTC naloxone nasal spray (Narcan) was approved by the FDA in March 2023.

Medication therapy management can also increase the likelihood of using statins in this population.

Four posters presented at this year’s American Pharmacists Association Annual Meeting & Exposition assessed the potential impact of pharmacist interventions on improving mental health outcomes.

According to posters presented at the 2024 American Pharmacists Association Annual Meeting and Exposition, pharmacists wish to play a bigger role in educating young people about the risks of vaping.

Access to counseling and education were strong predictors of being dispensed contraceptives.

Results from a meta-analysis on the side of effects of the psychedelic psilocybin were presented at the 2024 American Pharmacists Association Annual Meeting & Exposition.

Four posters presented at the American Pharmacists Association Annual Meeting and Exposition explored how individuals and health care providers have been handling the COVID-19 pandemic.

APhA 2024 will take place March 22 to March 25 in Orlando, Florida.

Pharmacists can provide support and guidance to patients during their month of fasting.

Two posters presented at APhA in Phoenix examined the efficacy of the Omnipod® 5 Automated Insulin Delivery System.

COVID-19 misinformation is common. A study presented at the annual APhA meeting examined how new pharmacy practitioners responded to misinformation and tried to minimize its spread.

Are pharmacists obligated to correct medical misinformation they encounter online?

From variants to vaccines, much has changed in the COVID-19 landscape.

Pharmacogenetic testing and therapeutic drug monitoring are feasible in the inpatient psychiatric treatment setting.

Emergency medical services runs increased in all 4 US Census regions.

It is crucial to have a measure to mitigate the possibility of seizures, according to researchers.

About 1 in 10 individuals in the United States have diabetes. A recent study examines how much they are paying on average for access to treatment for the common disease.

Survey respondents indicated a lack of comfort around recommending psilocybin therapy to patients.

New research examines how individuals with continuing COVID-19 symptoms are managing the virus.

Rural communities are often left without adequate assistance in times of need, but pharmacists can provide crucial care.

As sessions end for the day, head out to explore the city of Phoenix.

APhA 2023 will take place March 24 to March 27 in Phoenix, Arizona

Patients need digital pharmacists to monitor the growing armamentarium of digital therapeutics and the flood of patient-specific data